OncLive
OncLive, Plainsboro, NJ. 16K likes. OncLive covers every angle of your oncology practice, from new technology to treatment advances to important regulatory decisions
OncLive, Plainsboro, NJ. 16K likes. OncLive covers every angle of your oncology practice, from new technology to treatment advances to important regulatory decisions
HER2 gene expression is associated with prognostic and predictive value in patients with metastatic colorectal cancer.
Ramez N. Eskander, MD, discusses updated data for pembrolizumab plus chemotherapy in patients with advanced/recurrent endometrial cancer.
Health Canada has approved pembrolizumab plus chemotherapy for first-line, locally advanced, unresectable, or metastatic, HER2-negative gastric/GEJ cancer.
The FDA has mandated that the boxed warning for all approved CAR T-cell therapies be updated to include the serious risk of T-cell malignancies.
European Respiratory Society. 36,086 likes · 245 talking about this. With members in over 100 countries, the European Respiratory Society (ERS) aims to alleviate sufferi
R. Lor Randall, MD, FACS, discusses the changing field of orthopedic oncology and gives his takeaways from the American Academy of Orthopedic Surgeons Meeting.
A unique approach combining genomic and sensitivity testing with machine learning was feasible for guiding treatment selection in pediatric cancers.
The FDA has approved alectinib as adjuvant treatment in select patients with ALK-positive non–small cell lung cancer.
Matthew S. Johnson, MD, discusses a pilot study of Y-90 radioembolization plus pembrolizumab in patients with poor-prognosis hepatocellular carcinoma.
Idalid Franco, MD, MPH, discusses the integration of immunotherapy, molecular biomarkers, and risk factors for recurrence into the endometrial cancer paradigm.